Overcoming Drug Resistance in Advanced Prostate Cancer by Drug Repurposing
Prostate cancer (PCa) is the second most common cancer in men. Common treatments include active surveillance, surgery, or radiation. Androgen deprivation therapy and chemotherapy are usually reserved for advanced disease or biochemical recurrence, such as castration-resistant prostate cancer (CRPC),...
Guardat en:
| Autors principals: | , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
MDPI AG
2022-02-01
|
| Col·lecció: | Medical Sciences |
| Matèries: | |
| Accés en línia: | https://www.mdpi.com/2076-3271/10/1/15 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|